Business

Nike names Pfizer executive David Denton as new chief financial officer

Nike tapped Pfizer finance chief David Denton to replace Matthew Friend as it presses a margin and inventory reset, and investors initially bid up the stock.

Sarah Chen··2 min read
Published
Listen to this article0:00 min
Nike names Pfizer executive David Denton as new chief financial officer
AI-generated illustration

Nike named Pfizer finance chief David M. Denton as its next chief financial officer, bringing in a veteran turnaround operator as the company works through slower sales, margin pressure and a more demanding inventory cleanup. The move puts one of the most sensitive jobs in the company in the hands of an executive whose career has centered on large, complex consumer and retail businesses.

Nike said Denton will join as executive vice president and chief financial officer on August 17. Matthew Friend will step down the same day and stay through September 4 to help with an orderly transition. Denton is 60 and has led Pfizer’s finance organization since May 2022. Pfizer said he will leave on August 15 for a consumer-goods opportunity outside pharmaceuticals.

AI-generated illustration
AI-generated illustration

Denton arrives with experience that fits Nike’s current strain. Before Pfizer, he was CFO and executive vice president of Lowe’s Companies Inc. At CVS Health, he served as CFO and executive vice president and played a role in the integration of Caremark and the December 2017 CVS-Aetna acquisition. Nike’s leadership said his background reflected the discipline it wants as the brand tries to sharpen execution, manage capital allocation and restore long-term value creation.

Data visualization chart
Data Visualisation

The hiring lands at a difficult point for Nike’s business. In fiscal 2025, the company’s revenue fell 10% to $46.3 billion, while fourth-quarter revenue dropped 12% to $11.1 billion. Gross margin in that quarter slid 440 basis points to 40.3%, showing how much pressure the brand faced as it worked through product and channel disruptions.

The strain has continued into fiscal 2026. In the third quarter, Nike posted revenue of $11.3 billion, flat on a reported basis, while gross margin fell 130 basis points to 40.2%. Nike said higher tariffs in North America were a primary reason for the margin decline. NIKE Direct revenue fell 4% in the quarter, and Converse revenue dropped 35%, underscoring how uneven the recovery has been across the portfolio.

The timing also raises the stakes for the new finance chief. Nike plans to report fiscal fourth-quarter 2026 results on June 30, just days after the leadership change was announced. Some market reports said Nike shares rose more than 2% in after-hours trading after the news, suggesting investors welcomed a finance chief with experience in major corporate restructurings and capital-heavy operations.

For Nike, the CFO appointment is more than a routine handoff. The company is trying to steady revenue, protect margins and regain control over product flow after a difficult stretch under chief executive Elliott Hill, who returned in 2024. Denton’s arrival signals that Nike wants its next phase of recovery to be measured less by brand promise and more by operational discipline.

This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.

Know something we missed? Have a correction or additional information?

Submit a Tip

Never miss a story.

Get Prism News updates weekly. The top stories delivered to your inbox.

Free forever · Unsubscribe anytime

Discussion

More in Business